X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB IPCA LABS UNICHEM LAB/
IPCA LABS
 
P/E (TTM) x 22.0 27.9 78.8% View Chart
P/BV x 2.3 2.1 108.2% View Chart
Dividend Yield % 0.8 0.2 341.5%  

Financials

 UNICHEM LAB   IPCA LABS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
IPCA LABS
Mar-17
UNICHEM LAB/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs334643 51.9%   
Low Rs174503 34.6%   
Sales per share (Unadj.) Rs146.9254.4 57.7%  
Earnings per share (Unadj.) Rs11.916.1 74.0%  
Cash flow per share (Unadj.) Rs16.229.8 54.4%  
Dividends per share (Unadj.) Rs2.001.00 200.0%  
Dividend yield (eoy) %0.80.2 451.1%  
Book value per share (Unadj.) Rs105.1194.6 54.0%  
Shares outstanding (eoy) m90.84126.20 72.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.72.3 76.8%   
Avg P/E ratio x21.435.7 59.9%  
P/CF ratio (eoy) x15.719.2 81.6%  
Price / Book Value ratio x2.42.9 82.1%  
Dividend payout %16.86.2 270.2%   
Avg Mkt Cap Rs m23,07372,300 31.9%   
No. of employees `0005.713.3 42.6%   
Total wages/salary Rs m2,5586,960 36.8%   
Avg. sales/employee Rs Th2,352.52,413.5 97.5%   
Avg. wages/employee Rs Th450.9523.2 86.2%   
Avg. net profit/employee Rs Th190.4152.4 124.9%   
INCOME DATA
Net Sales Rs m13,34632,106 41.6%  
Other income Rs m192226 85.0%   
Total revenues Rs m13,53832,332 41.9%   
Gross profit Rs m1,6394,448 36.8%  
Depreciation Rs m3901,730 22.5%   
Interest Rs m29241 12.0%   
Profit before tax Rs m1,4122,703 52.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293675 43.4%   
Profit after tax Rs m1,0802,028 53.3%  
Gross profit margin %12.313.9 88.7%  
Effective tax rate %20.725.0 83.0%   
Net profit margin %8.16.3 128.2%  
BALANCE SHEET DATA
Current assets Rs m5,97917,340 34.5%   
Current liabilities Rs m2,4329,559 25.4%   
Net working cap to sales %26.624.2 109.7%  
Current ratio x2.51.8 135.5%  
Inventory Days Days63100 62.9%  
Debtors Days Days6057 106.2%  
Net fixed assets Rs m6,40320,779 30.8%   
Share capital Rs m182252 72.0%   
"Free" reserves Rs m9,29324,499 37.9%   
Net worth Rs m9,54824,553 38.9%   
Long term debt Rs m2303,517 6.6%   
Total assets Rs m12,84339,595 32.4%  
Interest coverage x50.012.2 409.2%   
Debt to equity ratio x00.1 16.8%  
Sales to assets ratio x1.00.8 128.2%   
Return on assets %8.65.7 150.7%  
Return on equity %11.38.3 137.0%  
Return on capital %14.310.5 136.7%  
Exports to sales %29.248.6 60.1%   
Imports to sales %6.314.2 44.6%   
Exports (fob) Rs m3,90015,617 25.0%   
Imports (cif) Rs m8474,571 18.5%   
Fx inflow Rs m4,35615,617 27.9%   
Fx outflow Rs m1,1625,828 19.9%   
Net fx Rs m3,1949,790 32.6%   
CASH FLOW
From Operations Rs m1,1192,764 40.5%  
From Investments Rs m-853-1,432 59.6%  
From Financial Activity Rs m-334-1,591 21.0%  
Net Cashflow Rs m-68-259 26.4%  

Share Holding

Indian Promoters % 50.1 45.9 109.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 11.4 132.5%  
FIIs % 3.0 25.3 11.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 17.4 182.2%  
Shareholders   20,176 36,892 54.7%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SANOFI INDIA  NOVARTIS  ALEMBIC PHARMA  ORCHID PHARMA LTD  PFIZER  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Lupin up 4%(01:30 pm)

After opening the day flat, share markets in India remained rangebound and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 24, 2017 02:34 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS